Papers
6
Total Citations
390
H-Index
6
About
Ganesh Sivarajan is a leading urologic oncologist whose research has fundamentally shaped the modern approach to kidney cancer surgery, particularly through the lens of robotic technology. His work centers on optimizing oncologic outcomes in robot-assisted partial nephrectomy (RAPN), a minimally invasive procedure to remove kidney tumors while preserving healthy tissue. In his highly cited multi-institutional study, "Positive Surgical Margins in Robot-Assisted Partial Nephrectomy" (145 citations), Sivarajan provided critical evidence that positive surgical margins do not necessarily compromise cancer control, helping to expand the safe application of this technique. He further advanced the field by identifying predictors and outcomes of tumor up-staging from clinical T1 to pathological T3a after RAPN (119 citations), offering surgeons vital preoperative risk stratification tools. Beyond individual patient outcomes, Sivarajan has examined the broader impact of robotic diffusion on hospital-level utilization of partial nephrectomy, demonstrating that the technology's adoption has improved care by increasing the use of nephron-sparing surgery. His work, which also includes comparative analyses of lymphadenectomy techniques and complex reconstructive cases, has been cited over 390 times, cementing his reputation as a key voice in evidence-based robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6